Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04261426
Recruitment Status : Not yet recruiting
First Posted : February 7, 2020
Last Update Posted : February 7, 2020
Sponsor:
Collaborator:
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Information provided by (Responsible Party):
LI Taisheng, Peking Union Medical College Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : April 30, 2020
Estimated Study Completion Date : June 30, 2020